Theranexus   Report issue

For profit Phase 1 Phase 2
Founded: Orsay France (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2015
NCT03182413
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Theranexus